IZumi Bio And Kyoto University Form Collaboration To Advance Induced Pluripotent Stem Cell Technology

iZumi Bio, Inc., and Kyoto University’s Center for iPS Cell Research and Application (CiRA), today announced a collaboration to promote the basic research, development and application of induced pluripotent stem (iPS) cell technology - a form of cellular reprogramming which originated in Japan - with the goal of advancing drug discovery and enabling cell-based therapies.

More: continued here

Filed under: Stem Cell Research on April 19th, 2009